Empagliflozin Has Kidney Protective Effects in Acute Myocardial Infarction

Follow Drugslib on

By Elana Gotkine HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on June 26, 2025.

via HealthDay

THURSDAY, June 26, 2025 -- Empagliflozin has kidney protective effects and reduces heart failure outcomes across baseline kidney function among patients with acute myocardial infarction (MI), according to a study published online June 13 in Nature Cardiovascular Research.

Rahul Aggarwal, M.D., from Harvard Medical School in Boston, and colleagues examined the cardiovascular-kidney effects and safety of empagliflozin in a secondary analysis of a multicenter, clinical trial involving 6,522 patients with acute MI and risk for heart failure who were randomly allocated to receive empagliflozin or placebo.

The researchers found that the mean estimated glomerular filtration rate at baseline was 76.1 mL/min/1.73 m2; longitudinal kidney function data were available for 1,152 treated patients from select countries. Compared with baseline, by 24 months, the estimated glomerular filtration rate was similar in the empagliflozin group, but decreased in the placebo group. Irrespective of kidney function, the total adverse events of heart failure or all-cause mortality were reduced with empagliflozin. Similar 30-day adverse event rates were seen by treatment group, which were consistent across baseline kidney function.

"Empagliflozin demonstrated beneficial kidney-protective effects, reduced heart failure outcomes and was safe to initiate soon after acute MI," the authors write. "The cardiovascular-kidney benefits and safety of empagliflozin were consistent irrespective of baseline kidney function."

Several authors disclosed ties to biopharmaceutical companies; the study was funded by the Boehringer Ingelheim and Eli Lilly and Company Alliance.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-06-27 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords